Nakamura Y, Kaneva K, Lo C, Neems D, et al. A tumor-naive ctDNA assay detects minimal residual disease in resected stage II or III colorectal cancer and predicts recurrence: subset analysis from the GALAXY study in CIRCULATE-Japan. Clin Cancer Res 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-2396.
PMID: 39513962